---
$id: https://graph.org.ai/products/commodity/51343701
$type: Product
source: UNSPSC
code: "51343701"
title: "Tanomastat"
class: "51343700"
classTitle: "Antiviral ketones and morpholines and nitriles and pyridazines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tanomastat

**UNSPSC Code**: 51343701
**Class**: [Antiviral ketones and morpholines and nitriles and pyridazines](Antiviral ketones and morpholines and nitriles and pyridazines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a matrix metalloproteinase inhibitor with the molecular formula C23H19ClO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AM1ZX94EXH, chemically known as (s)-4-chloro-gamma-oxo-alpha-((phenylthio)methyl)(1,1-biphenyl)-4-butanoic acid but generally known as tanomastat, which bears US NIH Compound Identifier 177347. The term TANOMASTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule Tanomastat under HS 29309085 and SITC 51549. As of Q4 2014, TANOMASTAT remains the US FDA Preferred Term for this commodity. Tanomastat bears US NLM identifiers UMLS ID C0393069 and NCI Concept Code C1705. SMILES: C1CCC(CC1)SC[C@@H](CC(=O)C2CCC(CC2)C3CCC(CC3)CL)C(=O)O.

